MoonLake Immunotherapeutics
MLTX | NASDAQ
$12.81
+$0.26 (+2.07%)
Sep 22, 2026, 1:37 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -265.22M | -259.47M | -230.32M | -212.91M | -178.33M | -147.04M | -120.45M | -82.29M | -57.79M | -45.38M | -43.63M | -52.66M | -55.78M | -55.55M | -59.21M | -57.06M | -48.61M | -69.17M | -53.37M | -39.05M | -32.76M | -76.29K |
Depreciation & Amortization | 3.24M | 3.08M | 2.62M | 3.17M | 1.83M | 1.43M | 1.38M | 86.73K | 676.58K | 337.87K | 13.16K | 13.16K | 13.16K | 13.16K | 12.36K | 11.56K | 10.53K | 7.25K | 4.76K | 2.27K | n/a | n/a |
Stock-Based Compensation | 23.2M | 23.96M | 12.9M | 11.24M | 9.38M | 7.89M | 7.28M | 6.95M | 6.54M | 6.21M | 7.11M | 8.1M | 9.26M | 10.24M | 9.65M | 14.82M | 14.09M | 12.85M | 10.86M | 3.11M | 1.25M | n/a |
Other Working Capital | 21.42M | 10.73M | 20.83M | 17.59M | 4.56M | 185.86K | -2M | -4.73M | -12.63M | -8.51M | -5.38M | 2.56M | 4.2M | -3M | -3.68M | -4.41M | -4.85M | 4.61M | 4.54M | 3.54M | 1.23M | -13.69K |
Other Non-Cash Items | 978K | -390K | -703K | -1.22M | -189.37K | 1.17M | 916.63K | 1.17M | -177.06K | -229.34K | -50.81K | 115.56K | 212.45K | -13.57M | -13.53M | -7.82M | -7.71M | 37.53M | 37.43M | 31.57M | 31.42M | -17.82K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.47K | 13.51K | n/a | n/a | -37.47K | -13.51K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 12.63M | 8.66M | 19.5M | 15.97M | 2.82M | -1.31M | -3.78M | -6.42M | -13.69M | -9.63M | -6.22M | 2.44M | 4.18M | -2.78M | -3.73M | -4.85M | -5.34M | 4.12M | 4.48M | 3.48M | 1.23M | -13.69K |
Operating Cash Flow | -225.18M | -224.15M | -196.01M | -185.69M | -166.42M | -139.78M | -116.59M | -80.46M | -64.43M | -48.7M | -42.78M | -42.03M | -42.13M | -64.12M | -69.29M | -65.14M | -57.81M | -23.65M | -9.57M | -2.12M | -101.66K | -107.8K |
Capital Expenditures | n/a | n/a | -35K | -210.57K | -342.52K | -342.52K | -519.52K | -628.59K | -496.63K | -496.63K | -284.63K | -1 | -1 | -16.01K | -32.02K | -50.39K | -62.04K | -46.03K | -30.03K | -11.65K | -5 | -5 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -176.98M | -235.89M | -265.37M | -353.15M | -382.33M | -351.11M | -350.28M | -175.76B | -175.91B | -175.82B | -175.73B | -175.73M | -42.23M | -42.23M | -42.23M | -42.23M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 235.9M | 382.74M | 468.4M | 438.93M | 438.12M | 230.91M | 145.2M | 262.57M | 176.33M | 190.31M | 150.83M | 33.68M | 32.32M | 19.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 175.56B | 175.56B | 175.56B | 175.56B | 9.76M | 9.89M | 9.88M | 9.86M | -42.23K | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 58.91M | 146.84M | 202.99M | 85.57M | 55.45M | -120.55M | -205.6M | 58.6M | -174.06M | -73.64M | -25.18M | -132.15M | n/a | -12.69M | -32.36M | -42.28M | -62.05K | -66.72K | -50.71K | -32.33K | -20.68K | n/a |
Debt Repayment | 24.47M | 24.47M | 73.02M | 73.02M | 73.02M | 73.02M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.15M | -150K | 14.85M | 14.85M | 30M | 15M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.2K | -6.2K | -6.2K | -6.2K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 480K | 480K | 480K | 480K | 182.86K | 182.86K | -1.38M | -4.13M | -4.31M | -4.31M | -2.75M | 3.79K | 3.79K | -101M | -100.99M | -101M | -101M | 3.79K | -58.06K | -54.78K | -58.06K | -58.06K |
Financial Cash Flow | 338.14M | 103.52M | 146M | 73.75M | 73.46M | 73.46M | 51.31M | 79.58M | 79.39M | 530.68M | 479.7M | 451.29M | 451.29M | 18.54M | 33.55M | 48.54M | 49.04M | 58.32M | 43.26M | 28.26M | 27.77M | -58.06K |
Net Cash Flow | 171.22M | 26.92M | 154.09M | -24.92M | -36.11M | -186.87M | -270.74M | 57.49M | -159M | 408.31M | 411.66M | 276.96M | 409.08M | -50.89M | -60.72M | -52.01M | -2.04M | 6.28M | 5.32M | -1.69M | -159.72K | -165.86K |
Free Cash Flow | -225.18M | -224.15M | -196.04M | -185.9M | -166.76M | -140.12M | -117.11M | -81.09M | -64.93M | -49.2M | -43.06M | -42.03M | -42.13M | -64.14M | -69.32M | -65.19M | -57.87M | -23.7M | -9.6M | -2.13M | -101.66K | -107.8K |
Adj. Free Cash Flow | -248.38M | -248.12M | -208.94M | -197.14M | -176.14M | -148.02M | -124.39M | -88.04M | -71.47M | -55.4M | -50.17M | -50.13M | -51.39M | -74.38M | -78.97M | -80.01M | -71.96M | -36.55M | -20.47M | -5.24M | -1.35M | -107.8K |
Maintenance CapEx | n/a | n/a | -35K | -210.57K | -342.52K | -342.52K | -519.52K | -347.24K | -215.29K | -215.29K | -3.29K | -1 | -1 | -3.29K | -5.78K | -8.26K | -10.53K | -7.25K | -4.76K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -281.35K | -281.35K | -281.35K | -281.35K | n/a | n/a | -12.72K | -26.24K | -42.13K | -51.51K | -38.79K | -25.27K | n/a | n/a | n/a |
Owner Earnings | -225.18M | -224.15M | -196.04M | -185.9M | -166.76M | -140.12M | -117.11M | -80.81M | -64.65M | -48.92M | -42.78M | -42.03M | -42.13M | -64.13M | -69.29M | -65.15M | -57.82M | -23.66M | -9.58M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MLTX